Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo F Buckley

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|June 29, 2018
Acute Myocardial Infarction after Laboratory-Confirmed Influenza InfectionLeo F Buckley
Journal of Cardiovascular Pharmacology|July 30, 2019
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical OutcomesLeo F Buckley, Peter Libby
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 18, 2018
Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to BedsideLeo F Buckley, Antonio Abbate
European Heart Journal|March 28, 2018
Interleukin-1 blockade in cardiovascular diseases: a clinical updateLeo F Buckley, Antonio Abbate
Arteriosclerosis, Thrombosis, and Vascular Biology|March 21, 2024
Colchicine's Role in Cardiovascular Disease ManagementLeo F Buckley, Peter Libby
Journal of Cardiovascular Pharmacology|November 9, 2020
Cardiac Myosin Activation for the Treatment of Systolic Heart FailureThomas D Bernier, Leo F Buckley
Circulation. Heart Failure|January 22, 2026
Tribulations of Randomized Controlled Trials: Testing the Inflammatory Hypothesis of Heart FailureLeo F Buckley, Brittany N Weber
F1000Research|January 17, 2020
Recent advances in the treatment of chronic heart failureLeo F Buckley, Amil M Shah
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 7, 2024
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020Omar S Alkhezi, Leo F Buckley, John Fanikos
Journal of Clinical Lipidology|May 5, 2020
Changes in nationwide Medicare and Medicaid expenditures on lipid-lowering therapies after proprotein convertase/subtilisin type 9 inhibitor availabilityLeo F Buckley, Clara Ting, Nayyra Fatani, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|June 29, 2018
Acute Myocardial Infarction after Laboratory-Confirmed Influenza InfectionLeo F Buckley
Journal of Cardiovascular Pharmacology|July 30, 2019
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical OutcomesLeo F Buckley, Peter Libby
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 18, 2018
Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to BedsideLeo F Buckley, Antonio Abbate
European Heart Journal|March 28, 2018
Interleukin-1 blockade in cardiovascular diseases: a clinical updateLeo F Buckley, Antonio Abbate
Arteriosclerosis, Thrombosis, and Vascular Biology|March 21, 2024
Colchicine's Role in Cardiovascular Disease ManagementLeo F Buckley, Peter Libby
Journal of Cardiovascular Pharmacology|November 9, 2020
Cardiac Myosin Activation for the Treatment of Systolic Heart FailureThomas D Bernier, Leo F Buckley
Circulation. Heart Failure|January 22, 2026
Tribulations of Randomized Controlled Trials: Testing the Inflammatory Hypothesis of Heart FailureLeo F Buckley, Brittany N Weber
F1000Research|January 17, 2020
Recent advances in the treatment of chronic heart failureLeo F Buckley, Amil M Shah
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 7, 2024
Trends in Oral Anticoagulant Use and Individual Expenditures Across the United States from 2014 to 2020Omar S Alkhezi, Leo F Buckley, John Fanikos
Journal of Clinical Lipidology|May 5, 2020
Changes in nationwide Medicare and Medicaid expenditures on lipid-lowering therapies after proprotein convertase/subtilisin type 9 inhibitor availabilityLeo F Buckley, Clara Ting, Nayyra Fatani, et al.
Pageof 9